Virosine-DR Drug Information [ Ranbaxy ]
Table of content
Virosine-DR category:
Active ingredients:
Virosine-DR companies and manufacturers:
General Information
Virosine-DR forms, composition and dosages:
- Capsules, Delayed Release; Oral; Didanosine 250 mg
- Capsules, Delayed Release; Oral; Didanosine 400 mg
Indications, usages and classification codes:
- J05AF02 - Didanosine
PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
- Apodasi Protein, Mexico
- Aso DDI Raffo Laboratorios
- Bandotan Teva
- DDIno BCM
- Dibistic Elvetium
- Didanosine Aurobindo
- Didanosine Barr Laboratories
- Didanox Cristalia Produtos Quimicos Farmaceuticos
- Dinex Cipla
- Listera Ovata Agglutinin BCM
- Megavir Gador
- Ronvir Pfizer
- Videx Bristol-Myers Squibb
- Videx EC Bristol-Myers Squibb
- Videx Pediatric Bristol-Myers Squibb
- Apodasi Protein, Mexico
- DDIno
- DDRetro Alkem Laboratories
- Didanosine Matrix Laboratories
- Didanosine Stada; Khuong Duy Pharmaceutical
- Abduce Farmanic
- Abrax C.T.S. Chemical Industries
- Abreva GlaxoSmithKline
- Acerpes Bioglan; Investi Farma; Ecosol; Riemser Arzneimittel
- Acic Hexal; Rowa Pharmaceuticals
- Acic Creme Hexal; Sandoz
- Acic Ophtal Hexal; Dr. Winzer Pharma
- Acic PI Hexal
- Aciclin Fidia Farmaceutici
- Aciclo Ahimsa Laboratorios
- Aciclo Basics
- Aciclo CT-Arzneimittel
- Aciclobene Ratiopharm
- Aciclobeta Betapharm Arzneimittel
- Aciclodan PharmaCoDane
- Acicloftal Bruschettini
- Aciclomed Cimed Industria de Medicamentos
- Aciclomed Ethimed
- Aciclophar Teva
- Aciclor Kley Hertz; Leti Laboratorios